Charles Jillings, CEO of Utilico, energized by strong economic momentum across Latin America. Watch the video here.
so today is the day that pharmacies in Belgium are going to be able to sell Eroxon and there is suppsed to be an advertising campaign. Will look around and see if I can find anything.
you're sorry, as usual misread it...dyslexia rules ko
not that scary as it still needs to be taken 1 to 2 hours before. With Eroxon it takes 10 minutes as can be used as part of foreplay.
imo what it does mean is the pill is on it's way out.
also there is no mention if it needs to be a perscription or otc.
I'm not to worried.....we knew other products were coming on the market....
Italian, I was pleased to see the RNS, as I like you wasn't sure if they would say.
Let's hope it's a short wait! I say this based on the 150 day rule that FUM pointed out in the previous RNS. That the clock stopping on the 150 day rule, to respond on the initital MED300 OCT request, when the FDA asked more questions. Then said clock is started again when replies recived....
Looking forward to seeing their results for 2022. Hopefully they will reveal more about the rollout globally and some forward guidance. But I won't hold my breath as last few year end results haven't been that exciting....
i see there is another unhappy punter on the Farmaline website.
looking on the Farmaline website it's Eroxon Stimgel (not sure if you made a typo Dactions)...guessing it for Stimulating Gel.
Also I noticed the reviews have gone down to 9 and the really bad review has been removed....god I need to get out more...lol
it now says 10 reviews. I think there is a time lag on the number of reviews to when they appear. I've only just seen the 1 star review even though I looked earlier
I agree the review might be bogus. But remember the gel doesn't work for everyone, so we will get negative reviews at some point.
I've only just listened to the interview and I think we should get the reply from the FDA sooner rather than later.
James, said that the whole process takes 150 days and when the FDA asks questions the 150 day counter stops. He also said it takes about 4 weeks to send a response back and that they had received the questions previously and they should get the answer back to them by the end of the month. James then said the clock starts again.
James also seemed to indicate that we might not need to wait until the end of the 2 qtr, as I assumed, but couldn't guarentee that. But if I am right it should be sooner rather than later.
So maybe someone could listen to the interview again and see if I am misheard.
If this is true, this also means that if FUM received the questions a while ago, why didn't they release the price sensitive information?
Looking at the two versions the one today appears to be an update from the original. The figures are slightly lower (at a quick glance) on the one today compared to the one in 2022. Or am I getting wrong....
I hadn't realised it was an old article. I checked the date on the yahoo site, so assumed it was new.
link to an Simply Wall Street article on Yahoohttps://uk.finance.yahoo.com/news/futura-medical-plc-lon-fum-051313119.html?guccounter=1&guce_referrer=aHR0cHM6Ly91ay5hZHZmbi5jb20v&guce_referrer_sig=AQAAAJUT7IalhWKokZIwfLqSOFfRN-is-3VRtP1WKHC4ctzbsyfDOge4gh6CkanqzNnQPEs7SHgScB0nQKUhPpbv2cylDG6m2aolEa7zWC80MMO3ppiocmS6AbMTfDPXpBtMqQalJDaE0NCDq0XKIWKnxbQBkYX02zIXOYGx3wLhZra_
Trdr must of missed that part and I reread to ensure...d'oh...must get better glasses
That is good information, but it does show up that the FUM have a communications issue and it takes there broker to get us data FUM shoud of supplied.
Liberum have said that FUM stated that the extra FDA questions are non clinical issues, why was this not in the RNS. If investors saw that they were nothing to do with clinical issue, would they have sold
I do agree the drop is over the top and in time we will now get FDA approval. But I really want FUM board to get there communcations together
Well that explains the constant fall in the share price.
Glad to hear that they finally acknowledge the product is on sale in the EU. Shame no time or informaiton regarding the release in the UK.
PDW, I also just received a reply from the PR team stating the same...
"In May 2022, Futura announced an exclusive licensing agreement with Cooper, a leading International independent self-care organisation for the rights to commercialise MED3000 throughout the EEA, the United Kingdom and Switzerland.
Futura is pleased to confirm that Cooper is on track to launch Eroxon™ in the first half of 2023, as previously guided, and has already commenced pre-launch activities and expects the first product supplies to be available in the coming months"
it is depressing with the constant falls, but at least the volumes have been small. Hopefully news will come shortly and give this a boost it needs...
Brugge95, you should write a review on the website, if you have time...glad to here it got things 'moving' lol
PDW, I'm turning into a man of emails (as I've sent several over the last year). I also emailed them yesterday saying roughly the same thing. You would have thought this would be something to brag about.
I am looking at the final finance report, in April, as will be interesting if they've received any milestone payments.